Satellos Bioscience Inc.: Satellos Bioscience Reports Q2 202

Toronto, Ontario--(Newsfile Corp. - August 29, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Corporation"), a regenerative medicine company aimed at developing therapeutics that change

Related Keywords

United States , Canada , Toronto , Ontario , Canadian , Christina Cameron , Ryan Mitchell , Michael Rudnicki , Regulatory Services Provider , Newsfile Corp , Amphotericinb Technologies Inc , Satellos Bioscience Inc , Venture Exchange , Business Development , Satellos , Ioscience , Reports , 022 , Financials , Operating , Results ,